
Engineer, Make more
mitochondria
for life
35,000+
Scientific papers integrated
7
Systemic diseases — early stage detection
8
Internal Validation studies completed
We are a TechBio company creating a universe of cellular communication network to define the future of early disease diagnostics
The cell collective & their mitochondria send bioelectric signals with the body across body organs & communicate current state of morphogenesis to maintain cell, molecular, tissue & organ level health.
By understanding, manipulating & reprogramming the bioelectric communication network & mitochondria, we could suggest restorative protocols for degenerative diseases & cancer, inadequately addressed by current practice.


Reprogram your microbiome & mitochondria to repair & replace dysfunctional cells
By identifying defects in energetic processes of mitochondria & dysregulation in its communication network using multi-omics, our biophysics+ machine learning platform is early detecting onset of degenerative diseases & cancer & delivering regenerative therapeutics to reinstate anatomical homeostasis.
Intelligent microbiome–mitochondria crosstalk.
Our Cellular Bioelectrome Platform is powered by science at every layer.
Our platform drives intelligent microbiome–mitochondria crosstalk by translating decades of biophysics research into a live computational model of cellular health.
The result: the earliest possible detection of disease onset, and a clear pathway to restoration.
Powered byWhat we measure.
A comprehensive map of the bioelectric communication network — from microbiome to mitochondria.
Systemic diseases we decipher at early stage.
When cells shrink their cognitive space
Our platform measures how mitochondria responds to cellular stressors caused by microbiome and external toxins. The resultant cytokines over expression leads to functional dysregulation and breakdown in the cellular communication systems, which makes affected cells detach from cell collective and pursue their local unicellular goals rather than long term morphogenetic objectives.
This translates into onset of degenerative disease and cancer. By identifying the change in allostatic state and cellular recalibrations at an early stage, we recommend regenerative therapeutics interventions that reinstates anatomical homeostasis.
Degenerative Diseases CancerPartner with us to establish the future of-Early Disease Diagnosis
We are onboarding healthcare ecosystem players — longevity clinics, hospitals, healthcare practitioners, diagnostic testing companies, DNA testing companies and functional medicine specialists who are looking to incorporate early disease diagnostics in their current clinical practices.
Real stories. Real results.
Hear directly from customers already experiencing the power of early cellular diagnostics.
All my digestive issues have normalised, I feel good. This regime has totally improved my quality of life.
Lost weight and took control of my hormonal issues that were troubling me from a long time.
In our 40s, we feel rejuvenated, recharged and we feel more energetic, thanks to the early diagnosis and regerative therapeutic interventions.
Energy Resistance Approach for Early Detection
Our platform identifies breakdown in the energetic processes of the mitochondria to detect cellular recalibration that precedes disease diagnosis and delivers mechanisms of action to drive long term morphogenetic objectives.
Our data matters – 35 Bn Cellular datasets and counting
The rejuvenating switch for a dormant system.
Our bioelectrome model uses mathematics to suggest regenerative therapeutics & nutrition interventions that direct the impacted cancer/dysfunction cell to rejoin the cellular collective to drive cognitive light cone scaling objectives. Our tech tools enable you to evaluate, track & monitor a 360° view of your cellular biology.
Team of innovators, inventors & entrepreneurs.
We are a team of obsessed entrepreneurs driving the potential of mitochondrial reprogramming for the future of early cancer diagnostics.


